IMPACT BIOMEDICAL INC. (IBO) Form 10-K Annual Reports
IMPACT BIOMEDICAL INC. (IBO) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: IBO
CIK: 1834105
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Grassi & Co., CPAs, P.C.
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerPatrick Fahey
Audit LocationJericho, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-09 | 2026-09-23 | 8-K | 0001493152-26-046572 | View SEC Doc Filr Page |
| 4 | 2026-09-24 | 2026-09-22 | 4 | 0001493152-26-044207 | View SEC Doc Filr Page |
| 425 | 2026-09-17 | — | 425 | 0001493152-26-042978 | View SEC Doc Filr Page |
| 8-K | 2026-09-17 | 2026-09-16 | 8-K | 0001493152-26-042975 | View SEC Doc Filr Page |
| 425 | 2026-09-15 | — | 425 | 0001493152-26-042640 | View SEC Doc Filr Page |
| 8-K | 2026-09-15 | 2026-09-14 | 8-K | 0001493152-26-042635 | View SEC Doc Filr Page |
| 10-Q | 2026-08-07 | 2026-06-30 | 10-Q | 0001493152-26-036601 | View SEC Doc Filr Page |
| 10-Q | 2026-05-12 | 2026-03-31 | 10-Q | 0001493152-26-022512 | View SEC Doc Filr Page |
| 144 | 2026-04-29 | — | 144 Filing | 0001493152-26-019682 | View SEC Doc Filr Page |
| S-8 POS | 2026-04-22 | — | S-8 POS | 0001493152-26-018572 | View SEC Doc Filr Page |
| S-8 POS | 2026-04-06 | — | S-8 POS | 0001493152-26-015316 | View SEC Doc Filr Page |
| 4 | 2026-03-30 | 2026-03-25 | 4 | 0001493152-26-013708 | View SEC Doc Filr Page |
| 4 | 2026-03-25 | 2026-03-23 | 4 | 0001493152-26-012746 | View SEC Doc Filr Page |
| 10-K | 2026-03-11 | 2025-12-31 | 10-K | 0001493152-26-009711 | View SEC Doc Filr Page |
| 8-K | 2026-03-04 | 2026-02-27 | 8-K | 0001493152-26-008879 | View SEC Doc Filr Page |
| 4 | 2026-01-06 | 2025-05-22 | 4 | 0001493152-26-000635 | View SEC Doc Filr Page |
| DEF 14C | 2025-12-30 | 2025-12-30 | DEF 14C | 0001493152-25-029621 | View SEC Doc Filr Page |
| PRE 14C | 2025-12-11 | 2025-12-11 | PRE 14C | 0001493152-25-027284 | View SEC Doc Filr Page |
| 10-Q | 2025-11-07 | 2025-09-30 | 10-Q | 0001493152-25-021286 | View SEC Doc Filr Page |
| 8-K | 2025-11-06 | 2025-11-05 | 8-K | 0001493152-25-021066 | View SEC Doc Filr Page |
| 8-K | 2025-10-27 | 2025-10-24 | 8-K | 0001493152-25-019734 | View SEC Doc Filr Page |
| DEF 14A | 2025-09-22 | 2025-09-22 | DEF 14A | 0001493152-25-014484 | View SEC Doc Filr Page |
| DEF 14C | 2025-09-09 | 2025-09-09 | DEF 14C | 0001641172-25-026976 | View SEC Doc Filr Page |
| PRE 14C | 2025-08-25 | 2025-08-25 | PRE 14C | 0001641172-25-025413 | View SEC Doc Filr Page |
| 10-Q | 2025-08-14 | 2025-06-30 | 10-Q | 0001641172-25-023809 | View SEC Doc Filr Page |